Axona^® is a prescription medical food intended for the clinical dietary management of the metabolic processes associated with mild to moderate Alzheimer’s disease.

The human brain relies almost exclusively on glucose as a source of energy. Research shows that, in Alzheimer’s disease patients, there is a dramatic drop in the brain’s ability to metabolize glucose.

Axona is a medical food regulated by the FDA that addresses energy deficiencies in the brain by providing an alternative source of energy. In clinical trials, patients taking Axona experienced cognitive improvement in 45 days.

Axona has demonstrated safety and effectiveness in clinical trials. Axona is available by prescription only and its use must be supervised by a physician. For more detailed information on the FDA category of medical foods, see About Medical Foods.

This website contains information relating to various medical conditions and their therapies. Such information is provided for educational purposes only, does not constitute medical advice, and is not meant to be a substitute for the advice of a physician or other healthcare professional. You should not use this information for diagnosing a health problem or disease. In order for you to make intelligent healthcare decisions, you should always consult with a physician or healthcare provider for your, or your loved one's, personal medical needs.

This site is intended for residents of the United States only. Axona^® is available in the United States only.

The licensed material on this website is being used for illustrative purposes only; and any person depicted in the licensed material, if any, is a model.

Axona^® and the Axona^® logo are registered trademarks of Accera, Inc. There is still more you can do in AD is a trademark of Accera, Inc. AC-10-137